This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,711.70 firm-fixed price delivery order is for the supply of Gadavist 7.5 MMol/7.5 ML vials, a medical imaging contrast agent.
The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
The contract award did not utilize any set-aside designations, indicating open competition. In addition to the DLA contract, Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, which covers similar medical products and prescription drugs.
Generated 2/19/25, 9:04 AM